Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma

Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma

Cholangiocarcinoma (CCA) is the second most common primary liver malignancy and carries a dismal prognosis due to difficulties in achieving an optimal resection, and poor response to current standard-of-care systemic therapies. We previously devised a CTLA4-PD-L1 DNA cancer vaccine (DNA vaccine) and...

Full description

Bibliographic Details
Main Authors:	Yi-Ru Pan, Chiao-En Wu, Wen-Kuan Huang, Ming-Huang Chen, Keng-Hsueh Lan, Chun-Nan Yeh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Immunology
Subjects:	cholangiocarcinoma immune checkpoint proteins protein vaccine immune modulation therapeutic vaccine preventive vaccine
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.982196/full

Similar Items

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
by: Yi-Ru Pan, et al.
Published: (2020-11-01)

mRNA vaccine development for cholangiocarcinoma: a precise pipeline
by: Tian-Yu Tang, et al.
Published: (2022-07-01)

Cholangiocarcinoma in the Era of Immunotherapy
by: Eleni Manthopoulou, et al.
Published: (2023-06-01)

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
by: María Gutiérrez-Larrañaga, et al.
Published: (2021-09-01)

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma
by: Leyre Silva, et al.
Published: (2020-11-01)

Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy
by: Yu J, et al.
Published: (2021-05-01)

Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
by: Da Zhang, et al.
Published: (2021-03-01)

Immunotherapy in cholangiocarcinoma: From concept to clinical trials
by: Wen-Yan Yao, et al.
Published: (2021-06-01)

Immunotherapy in Advanced Biliary Tract Cancers
by: Alice Boilève, et al.
Published: (2021-03-01)

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinomaKey points
by: Xinjun Lu, et al.
Published: (2023-07-01)

Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
by: Xianzhe Yu, et al.
Published: (2023-04-01)

Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase
by: Milo Gatti, et al.
Published: (2021-01-01)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
by: Yujia Zhai, et al.
Published: (2021-04-01)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
by: David Repáraz, et al.
Published: (2022-02-01)

Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV
by: Gilberto Filaci, et al.
Published: (2018-10-01)

Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
by: Lu Cao, et al.
Published: (2021-05-01)

Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy
by: Tahseen H. Nasti, et al.
Published: (2021-11-01)

Immune checkpoint therapy in liver cancer
by: Feng Xu, et al.
Published: (2018-05-01)

Novel Chimeric Protein Vaccines Against Clostridium difficile Infection
by: Shaohui Wang, et al.
Published: (2018-10-01)

Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combining Immune Checkpoint Inhibitors in Unresectable Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis
by: Xue-Gang Yang, et al.
Published: (2022-07-01)

Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
by: Olivia A. Vogel, et al.
Published: (2020-02-01)

Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
by: Albert Jang, et al.
Published: (2023-12-01)

Combining photothermal ablation-based vaccine with immune checkpoint blockade for synergistic osteosarcoma immunotherapy
by: Xingyu Zhao, et al.
Published: (2021-01-01)

Current status and future prospects of Echinococcus multilocularis vaccine candidates: A systematic review
by: Maryam Hataminejad, et al.
Published: (2024-06-01)

Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
by: Li Zhuang, et al.
Published: (2024-01-01)

Chimeric vaccine design against the epidemic Langya Henipavirus using immunoinformatics and validation via immune simulation approaches
by: Aamir Fahira, et al.
Published: (2023-06-01)

Pulmonary Arterial Hypertension Induced by Immune Checkpoint Inhibitor Combined Therapy in a Patient with Intrahepatic Cholangiocarcinoma: A Case Report
by: Jingjing Zhang, et al.
Published: (2023-06-01)

Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model
by: Mathilde Bausart, et al.
Published: (2022-05-01)

Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
by: Alexander Piening, et al.
Published: (2022-12-01)

The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination
by: Nabila Seddiki, et al.
Published: (2020-07-01)

Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
by: Chang-Gon Kim, et al.
Published: (2021-07-01)

mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
by: Maryam Bidram, et al.
Published: (2021-09-01)

Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses
by: Li Chen, et al.
Published: (2024-07-01)

Vaccine development for pathogenic fungi: current status and future directions
by: Jéssica L. Chechi, et al.
Published: (2023-12-01)

Current status of cancer immunotherapy
by: Kono K
Published: (2014-04-01)

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational studyResearch in context
by: Melissa Bersanelli, et al.
Published: (2023-07-01)

Recent advancements in combination subunit vaccine development
by: Ming Tan, et al.
Published: (2017-01-01)

Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma
by: Zhuochao Zhang, et al.
Published: (2023-05-01)

A Structural View at Vaccine Development against <i>M. tuberculosis</i>
by: Maria Romano, et al.
Published: (2023-01-01)

Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
by: Zeynep Akbulut, et al.
Published: (2024-04-01)